trapidil has been researched along with Diabetic Retinopathy in 2 studies
Trapidil: A coronary vasodilator agent.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
Excerpt | Relevance | Reference |
---|---|---|
"In order to investigate the usefulness of prolonged administration of trapidil in the treatment of diabetic retinopathy, a follow-up study was carried out after the end of a placebo-controlled, double-blind study of the drug in case of the trapidil-treated group who continued to be treated with 300 mg/day of trapidil (Rocornal) (TT group) and those of the placebo group who were not given any treatment after the end of the study (PP group)." | 9.06 | [Clinical utility of long-term administration of trapidil (MDR-1865) in the treatment of diabetic retinopathy]. ( Fukuda, M; Nakashima, M; Yoshimoto, H, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuda, M | 2 |
Yoshimoto, H | 2 |
Nakashima, M | 1 |
Matsuyama, S | 1 |
Hirata, Y | 1 |
Watanabe, I | 1 |
Ichikawa, H | 1 |
Fukami, K | 1 |
Itoi, M | 1 |
Manabe, R | 1 |
Matsuo, N | 1 |
2 trials available for trapidil and Diabetic Retinopathy
Article | Year |
---|---|
[Clinical utility of long-term administration of trapidil (MDR-1865) in the treatment of diabetic retinopathy].
Topics: Adult; Aged; Clinical Trials as Topic; Diabetic Retinopathy; Double-Blind Method; Female; Follow-Up | 1990 |
[Clinical utility of trapidil (MDR-1865) in treating diabetic retinopathy--a multicenter, placebo-controlled, double-blind study].
Topics: Administration, Oral; Adult; Aged; Clinical Trials as Topic; Diabetic Retinopathy; Double-Blind Meth | 1986 |